Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase-Reference-Cited by-同舟云学术

Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase

Published:1985-01 Issue:2 Volume:146 Page:315-321
ISSN:0014-2956
Container-title:European Journal of Biochemistry
language:en
Short-container-title:Eur J Biochem

Author:

VACCARO Anna Maria,MUSCILLO Michele,SUZUKI Kunihiko

Publisher

Wiley

Subject

Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-1033.1985.tb08655.x/fullpdf

Reference26 articles.

1. Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's disease

2. A Deficiency of Glucocerebrosidase in Gaucher's Disease

3. 3. K. Suzuki, R. J. Desnick, S. Gatt, and G. A. Grabowski (1982 ) inGaucher Disease: a Century of Delineation and Research () pp.219 -230 , Alan R. Liss Inc., New York.

4. Isolation and characterization of glucosylsphingosine from Gaucher's spleen

5. Accumulation of Glucosylceramide and Glucosylsphingosine (Psychosine) in Cerebrum and Cerebellum in Infantile and Juvenile Gaucher Disease

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct;Nature Communications;2023-04-12

2. Microbial plant material–degrading enzymes;Green Sustainable Process for Chemical and Environmental Engineering and Science;2023

3. LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease;Biomolecules;2022-10-30

4. Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial;Brain;2022-10-18

5. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease;Advanced Drug Delivery Reviews;2022-08